Strongyloides stercoralis
"Strongyloides stercoralis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of parasitic nematode widely distributed in tropical and subtropical countries. The females and their larvae inhabit the mucosa of the intestinal tract, where they cause ulceration and diarrhea.
Descriptor ID |
D017171
|
MeSH Number(s) |
B01.050.500.500.294.400.875.640.680.700
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Strongyloides stercoralis".
Below are MeSH descriptors whose meaning is more specific than "Strongyloides stercoralis".
This graph shows the total number of publications written about "Strongyloides stercoralis" by people in this website by year, and whether "Strongyloides stercoralis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 3 | 0 | 3 |
2017 | 5 | 2 | 7 |
2018 | 8 | 1 | 9 |
2019 | 5 | 0 | 5 |
2020 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Strongyloides stercoralis" by people in Profiles.
-
Strongyloides in bronchoalveolar lavage fluid: practical implications in the COVID-19 era. J Travel Med. 2022 01 17; 29(1).
-
Eosinophilic appendicitis due to Strongyloides stercoralis: a challenging differential diagnosis for clinicians. BMJ Case Rep. 2021 Jun 01; 14(6).
-
Dexamethasone and COVID-19: Strategies in Low- and Middle-Income Countries to Tackle Steroid-Related Strongyloides Hyperinfection. Am J Trop Med Hyg. 2021 Mar 15; 104(5):1611-1612.
-
Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19. Travel Med Infect Dis. 2021 Mar-Apr; 40:101981.
-
Antimicrobial Management of Disseminated Strongyloidiasis in a COVID-19 Patient. Am J Trop Med Hyg. 2020 11; 103(5):2150.
-
Case Report: Disseminated Strongyloidiasis in a Patient with COVID-19. Am J Trop Med Hyg. 2020 10; 103(4):1590-1592.
-
Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia. Infection. 2021 Jun; 49(3):539-542.
-
COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection. JAMA. 2020 Aug 18; 324(7):623-624.
-
[Acute renal failure and rare severe complication of systemic steroid treatment in a 73-year-old woman]. Internist (Berl). 2019 Nov; 60(11):1201-1208.
-
Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial. Lancet Infect Dis. 2019 11; 19(11):1181-1190.